DOYLE JOHN BRENDAN (Chief Financial Officer) received a stock award from COGNITION THERAPEUTICS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/5/2026ACC: 0001104659-26-011074
Officer· Chief Financial Officer
Since Feb 2026
+173.08K
Net shares
Net buyer
$27.7K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
200K acquired · 26.92K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+200K
Price / share
—
Trade value
—
% of position
44.8%
2/3/2026
445.99K→645.99K
Common Stock
Direct
Shares
−26.92K
Price / share
$1.03
Trade value
$27.73K
% of position
4.2%
2/4/2026
645.99K→619.07K
Total
Net shares
+173.08K
Net value
-$27.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2026 | A · Award | +200K | — | — | 44.8% | 445.99K | 645.99K |
| Common Stock Direct | 2/4/2026 | F · Tax Withholding | −26.92K | $1.03 | $27.73K | 4.2% | 645.99K | 619.07K |
| Total | +173.08K | -$27.73K | ||||||
Derivative Transactions0
No derivative transactions reported